Drug intelligence / Profile preview

BOVIESTIMUL

Development stage: Unknown
Lead developer: UBM
Modality: Small Molecules
Administration: Oral

Overview

BOVIESTIMUL is a veterinary nutritional supplement and rumen stimulant developed and marketed by UBM (United Bio-Med) in Egypt. Formulated as a powder for oral administration, it is specifically designed for ruminants, including cattle, sheep, and goats. The product is used to manage digestive disorders such as anorexia, indigestion, and rumen stasis, and is often administered to restore appetite and normal rumen function following illness or antibiotic therapy. Its composition typically includes a blend of essential trace minerals (such as cobalt, zinc, and manganese), vitamins, and digestive enhancers that support the metabolic activity of rumen microflora and overall livestock productivity.

Brand names: BOVIESTIMUL
Other names: BOVIESTIMUL Powder

Targets

RM (Rumen microflora)

Beyond the preview

Go deeper on BOVIESTIMUL.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BOVIESTIMUL.

Explore the full profile